István Laki
Research Subjects
Research Interests
István Laki has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Adrienn Halász
Department of Pediatric Pulmonology (III), Svabhegy Children's Hospital, 1121 Budapest, Mártonhegyi út 6, Hungary
1 shared publicationAttilio Boner
U.O. di Pediatria, Dipartimento Sperimentale di Pediatria, Policlinico "G. Rossi," Verona, Italy
1 shared publicationEckard Hamelmann
Evangelisches Krankenhaus Bielefeld, Bielefeld, Germany; Allergy Center of the Ruhr University, Bochum, Germany
1 shared publicationEmőke Endreffy
Department of Pediatrics, University of Szeged, Albert Szent-Györgyi Medical School, 6725 Szeged, Korányi Fasor 14-15, Hungary
1 shared publicationEnikő Sólyom
Department of Pediatric Gastroenterology, Borsod-A-Z County and University Teaching Hospital, Pediatric Health Centre, 3526 Miskolc, Szentpéteri kapu 72-76, Hungary
1 shared publicationEszter Csiszér
Third Department of Pulmonology, National Korányi Institute for TB and Pulmonology, 1529 Budapest, Pihenő út 1, Hungary
1 shared publication
Latest Publications
- Open Access
- 1 November 2017
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 140 (5) , 1277-1287
A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma
- 1 November 2017
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 140 (5) , 1277-1287
Open AccessA phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma
- Open Access
- 5 September 2006
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 18 (11) , 1585-1590
The 8.1 ancestral MHC haplotype is associated with delayed onset of colonization in cystic fibrosis
Major cause of death in patients with cystic fibrosis (CF) is colonization with Staphylococcus aureus and Pseudomonas aeruginosa. The wide phenotypic variation in CF patients suggests that genes other than the cystic fibrosis transmembrane conductance regulator (CFTR) gene modify the disease. The 8.1 ancestral haplotype (8.1AH) in main histocompatibility complex is associated with alterations of the immune response. To study the influence of carriage of 8.1AH on frequency and onset of colonization in CF patients, DNA samples of 72 CF patients (39 homozygous and 33 heterozygous for ΔF508) were genotyped for member alleles of the 8.1AH: HLA-DQB1*0201, HLA-DRB1*0301, receptor for advanced glycation end products (AGER) −429C, HSP70-2 −1267G (HSP70-2G) and tumor necrosis factor-α (TNF-α) −308A (TNF2). Colonization was verified by regular clinical and bacteriological screening. Frequency of colonization was significantly (P = 0.012) lower in the 8.1AH carriers; age, gender and ΔF508 genotype-adjusted odds ratio to be colonized of the carriers versus non-carriers was 0.112 (0.024–0.520). According to survival analysis, patients with 8.1AH had significantly (P < 0.0001) longer colonization-free period compared with non-carriers. Our novel observations demonstrate that the 8.1AH is associated with delayed onset of colonization in CF, presumably by influencing defense mechanisms against infections.
- 5 September 2006
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 18 (11) , 1585-1590
Open AccessThe 8.1 ancestral MHC haplotype is associated with delayed onset of colonization in cystic fibrosis
Major cause of death in patients with cystic fibrosis (CF) is colonization with Staphylococcus aureus and Pseudomonas aeruginosa. The wide phenotypic variation in CF patients suggests that genes other than the cystic fibrosis transmembrane conductance regulator (CFTR) gene modify the disease. The 8.1 ancestral haplotype (8.1AH) in main histocompatibility complex is associated with alterations of the immune response. To study the influence of carriage of 8.1AH on frequency and onset of colonization in CF patients, DNA samples of 72 CF patients (39 homozygous and 33 heterozygous for ΔF508) were genotyped for member alleles of the 8.1AH: HLA-DQB1*0201, HLA-DRB1*0301, receptor for advanced glycation end products (AGER) −429C, HSP70-2 −1267G (HSP70-2G) and tumor necrosis factor-α (TNF-α) −308A (TNF2). Colonization was verified by regular clinical and bacteriological screening. Frequency of colonization was significantly (P = 0.012) lower in the 8.1AH carriers; age, gender and ΔF508 genotype-adjusted odds ratio to be colonized of the carriers versus non-carriers was 0.112 (0.024–0.520). According to survival analysis, patients with 8.1AH had significantly (P < 0.0001) longer colonization-free period compared with non-carriers. Our novel observations demonstrate that the 8.1AH is associated with delayed onset of colonization in CF, presumably by influencing defense mechanisms against infections.
- 9 July 2005
- Published by Springer Nature in European Journal of Applied Physiology
- Vol. 95 (2-3) , 172-178
Relationship between breath-hold time and physical performance in patients with cystic fibrosis
Rehabilitation including physiotherapy is an important part of the treatment used to help improve the quality of life of patients with cystic fibrosis (CF). The aim of this study was to determine the value of the breath-hold time as an index of exercise tolerance in patients with CF. Eighteen patients in different states of CF were included. The breath-hold time was measured in all patients. The fitness level was assessed by means of a progressive exercise test on a cycle-ergometer. During the test, oxygen uptake (VO2) and carbon dioxide elimination (VCO2) were measured breath by breath. The VO2 and working capacity (WC) were computed at the anaerobic threshold (AT) and at peak. Duration of breath-hold was 24.7±2.87 (mean ± SEM) seconds, varying between 10 and 58. The breath-hold time (BHT) displayed a significant correlation with VO2 (r=0.898), WC (r=0.899) at the AT, and the peak VO2 (r=0.895). Regression equations were: VO2 at the AT (ml/kg)=5.53+0.42×BHT and WC at the AT (watt/kg)=0.56+0.38×BHT Our results suggest that the voluntary breath-hold time might be a useful index for prediction of the exercise tolerance of CF patients.
- 9 July 2005
- Published by Springer Nature in European Journal of Applied Physiology
- Vol. 95 (2-3) , 172-178
Relationship between breath-hold time and physical performance in patients with cystic fibrosis
Rehabilitation including physiotherapy is an important part of the treatment used to help improve the quality of life of patients with cystic fibrosis (CF). The aim of this study was to determine the value of the breath-hold time as an index of exercise tolerance in patients with CF. Eighteen patients in different states of CF were included. The breath-hold time was measured in all patients. The fitness level was assessed by means of a progressive exercise test on a cycle-ergometer. During the test, oxygen uptake (VO2) and carbon dioxide elimination (VCO2) were measured breath by breath. The VO2 and working capacity (WC) were computed at the anaerobic threshold (AT) and at peak. Duration of breath-hold was 24.7±2.87 (mean ± SEM) seconds, varying between 10 and 58. The breath-hold time (BHT) displayed a significant correlation with VO2 (r=0.898), WC (r=0.899) at the AT, and the peak VO2 (r=0.895). Regression equations were: VO2 at the AT (ml/kg)=5.53+0.42×BHT and WC at the AT (watt/kg)=0.56+0.38×BHT Our results suggest that the voluntary breath-hold time might be a useful index for prediction of the exercise tolerance of CF patients.